Table of Content
- Introduction
- Definition of Parkinson's Disease Market
- Scope of the Report
- Methodology
- Executive Summary
- Market Overview
- Market Definition and Segmentation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porter's Five Forces Analysis
- PESTEL Analysis
- Parkinson's Disease Market, By Type:
- Juvenile Parkinson Disease
- Young-Onset Parkinson’s Disease
- Idiopathic Parkinson Disease
- Parkinson's Disease Market, By Age:
- Adult
- Pediatric
- Parkinson's Disease Market, By Diagnosis:
- CT Scan
- MRI Scan
- DaTSCAN-SPECT scan
- PET Scan
- Parkinson's Disease Market, By Drug Class:
- Carbidopa-Levodopa
- Carbidopa-Levodopa Infusion
- Dopamine Agonists
- Monoamine Oxidase B Inhibitors
- Catechol O-Methyltransferase Inhibitors
- Anticholinergics
- Amantadine
- Parkinson's Disease Market, By Geography:
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of Middle East & Africa
- North America
- Competitive Landscape
- Company Profiles
- Medtronic
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- Sunovion Pharmaceuticals
- Adamas Pharmaceuticals
- Neurocrine Biosciences
- Supernus Pharmaceuticals
- Kyowa Kirin
- AbbVie
- Integrative Research Laboratories AB
- Rusan Pharma
- Annovis Bio Inc.
- Cerevel Therapeutics
- AMneal Pharmaceuticals
- Medtronic
- Conclusion and Future Outlook
- Appendix
- Research Methodology
- About the Pharmanucleus
- Disclaimer